Neurology: Clinical Practice

Journal

Publication Venue For

  • Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple Sclerosis.  12:E58-E65. 2022
  • Disparities in Telehealth Care in Multiple Sclerosis.  12:223-233. 2022
  • Association of Performance on the Financial Capacity Instrument-Short Form With Brain Amyloid Load and Cortical Thickness in Older Adults.  12:113-124. 2022
  • Sources of Cannabis Information and Medical Guidance for Neurologic Use: NARCOMS Survey of People Living With Multiple Sclerosis.  12:102-112. 2022
  • Depressive Symptoms and Risk of Stroke in a National Cohort of Black and White Participants From REGARDS..  11:e454-e461. 2021
  • How Multiple Sclerosis Symptoms Vary by Age, Sex, and Race/Ethnicity..  11:335-341. 2021
  • Patient Perceptions of FDA Approval: Gaps in Education or Variation in Values?.  11:273-279. 2021
  • Uptake and Attitudes About Immunizations in People With Multiple Sclerosis..  11:327-334. 2021
  • Selecting an Optimal Antiplatelet Agent for Secondary Stroke Prevention..  11:e121-e128. 2021
  • Functional gastrointestinal disorders negatively affect health-related quality of life in MS.  9:381-390. 2019
  • Minding the gap in pediatric headache care: Can a focus on quality measures improve outcomes?.  9:187-193. 2019
  • Role of CYP2C19 alleles in the management of recurrent ischemic stroke.  9:140-144. 2019
  • Pseudobulbar affect prevalence and association with symptoms inmultiple sclerosis.  8:472-481. 2018
  • Chronic ambulatory electrocorticography findings preceding sudden death in epilepsy.  8:e1-e3. 2018
  • Identifying priority outcomes that influence selection of disease-modifying therapies in MS.  8:179-185. 2018
  • Effectiveness of alternative dose fingolimod for multiple sclerosis..  8:102-107. 2018
  • Neuroradiologic manifestations of Erdheim-Chester disease.  8:15-20. 2018
  • Neurologist–patient communication about epilepsy in the United States, Spain, and Germany.  8:93-101. 2018
  • Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants.  7:333-343. 2017
  • Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS.  6:397-408. 2016
  • Long-term registries.  6:97-99. 2016
  • To treat or not to treat, that really is not the question.  5:253-258. 2015
  • Cost-effectiveness analyses Beauty and the beast?.  3:436-439. 2013
  • Personalized medicine: The return of the house call?.  2:343-351. 2012
  • International Standard Serial Number (issn)

  • 2163-0402
  • Electronic International Standard Serial Number (eissn)

  • 2163-0933